GB201414706D0

GB201414706D0 - Calcitonin mimetics for treating diseases and disorders

Calcitonin mimetics for treating diseases and disorders

Info

Publication number: GB201414706D0
Authority: GB; United Kingdom
Prior art keywords: disorders; treating diseases; calcitonin mimetics; calcitonin; mimetics
Prior art date: 2014-08-19
Legal status : Ceased

Application number

GB201414706A

Current Assignee

KeyBioscience AG

Original Assignee

KeyBioscience AG

Priority date

2014-08-19

Filing date

2014-08-19

Publication date

2014-10-01

2014-08-19 Application filed by KeyBioscience AG filed Critical KeyBioscience AG

2014-08-19 Priority to GB201414706A priority Critical patent/GB201414706D0/en

2014-10-01 Publication of GB201414706D0 publication Critical patent/GB201414706D0/en

2014-11-10 Priority to EP14802345.0A priority patent/EP3068796B1/en

2014-11-10 Priority to JP2016530131A priority patent/JP6639389B2/en

2014-11-10 Priority to PCT/EP2014/074207 priority patent/WO2015071229A1/en

2014-11-10 Priority to TR2018/02765T priority patent/TR201802765T4/en

2014-11-10 Priority to US15/036,475 priority patent/US10232021B2/en

2014-11-10 Priority to SI201431101T priority patent/SI3321278T1/en

2014-11-10 Priority to LTEP17208140.8T priority patent/LT3321278T/en

2014-11-10 Priority to SI201430612T priority patent/SI3068796T1/en

2014-11-10 Priority to PL14802345T priority patent/PL3068796T3/en

2014-11-10 Priority to PL17208140T priority patent/PL3321278T3/en

2014-11-10 Priority to PT148023450T priority patent/PT3068796T/en

2014-11-10 Priority to RS20190279A priority patent/RS58530B1/en

2014-11-10 Priority to RS20180244A priority patent/RS57152B1/en

2014-11-10 Priority to HUE17208140 priority patent/HUE044465T2/en

2014-11-10 Priority to MX2016006049A priority patent/MX2016006049A/en

2014-11-10 Priority to CN201480062032.2A priority patent/CN105722854B/en

2014-11-10 Priority to DK14802345.0T priority patent/DK3068796T3/en

2014-11-10 Priority to BR112016010643A priority patent/BR112016010643A2/en

2014-11-10 Priority to HUE14802345A priority patent/HUE037663T2/en

2014-11-10 Priority to EP18208763.5A priority patent/EP3470422A1/en

2014-11-10 Priority to NO14802345A priority patent/NO3068796T3/no

2014-11-10 Priority to AU2014350328A priority patent/AU2014350328B2/en

2014-11-10 Priority to DK17208140.8T priority patent/DK3321278T3/en

2014-11-10 Priority to ES14802345.0T priority patent/ES2660788T3/en

2014-11-10 Priority to EP17208140.8A priority patent/EP3321278B1/en

2014-11-10 Priority to CA2928654A priority patent/CA2928654A1/en

2014-11-10 Priority to ES17208140T priority patent/ES2713851T3/en

2014-11-10 Priority to KR1020167015410A priority patent/KR20160075794A/en

2014-11-10 Priority to LTEP14802345.0T priority patent/LT3068796T/en

2014-11-10 Priority to PT17208140T priority patent/PT3321278T/en

2014-11-10 Priority to RU2016123180A priority patent/RU2689551C1/en

2016-04-15 Priority to PH12016500705A priority patent/PH12016500705A1/en

2018-02-26 Priority to HRP20180337TT priority patent/HRP20180337T1/en

2018-02-28 Priority to CY20181100253T priority patent/CY1119976T1/en

2018-04-09 Priority to AU2018202480A priority patent/AU2018202480A1/en

2019-01-21 Priority to US16/252,780 priority patent/US20190142903A1/en

2019-02-25 Priority to HRP20190356TT priority patent/HRP20190356T1/en

2019-02-28 Priority to CY20191100252T priority patent/CY1121332T1/en

Status Ceased legal-status Critical Current

Links

GB201414706A 2013-11-14 2014-08-19 Calcitonin mimetics for treating diseases and disorders Ceased GB201414706D0 (en)